Tokyo University of Pharmacy and Life Sciences · Department of Pharmacy / Faculty of Pharmaceutical Sciences · 講師

Research keywordspharmacoepidemiology・adverse event reporting systems・drug-drug interactions・chemotherapy-induced peripheral neuropathy・thromboembolic risk・methotrexate toxicity・pre-eclampsia therapeutics・anti-angiogenic agents・breast cancer pharmacology・real-world drug safety

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Association of hypoglycemic agents with the risk of platinum-based chemotherapy-induced peripheral neuropathy in patients with type 2 diabetes mellitus.2026 · Oncology
• Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents.2026 · Scientific reports
• Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis.2026 · Frontiers in pharmacology
• Differences in Approved Doses and Drug Lag in Drugs Approved between 2012 and 2021: A Comparison between Japan and the U.S.2025 · Biological & pharmaceutical bulletin

• 抗がん薬誘発末梢神経障害を修飾する新たな薬物の探索～情報・基礎・臨床の融合研究～2024 · 科学研究費助成事業
• 妊娠高血圧腎症の治療薬はベバシズマブの薬効を減弱するか？2019
• 自己免疫性水疱症におけるグルココルチコイドの薬力学2003 · 臨床薬理研究振興財団助成金

• Official profile